Skip to main content

News Archive

News Archive - School of Medicine

Phase III Clinical Trial to Evaluate Calcium Channel Blocker for Parkinson’s

September 30, 2014

Researchers at the University of California, San Diego School of Medicine have launched a Phase III clinical trial to evaluate the drug isradipine, a calcium channel blocker often used to treat high blood pressure, as a potential new treatment for Parkinson disease. The goal of the study is to determine whether the drug can slow the progression of the disease by keeping the brain’s dopamine-producing cells healthier for a longer period of time.

Four UC San Diego Teams Win NIH Grants from Obama’s BRAIN Initiative

September 30, 2014

Four teams of scientists at UC San Diego will receive research grants from the National Institutes of Health that will help lay the groundwork for visualizing the circuits of the brain and how they work, the agency announced at a White House ceremony today.

A “Frenemy” in Parkinson’s Disease Takes to Crowdsourcing

September 29, 2014

Researchers have found that a key neuronal protein called alpha-synuclein normally gathers in synapses, where aggregates of it help regulate neurotransmissions. In overabundance, though, a-synuclein can choke off communication altogether, leading to neuronal death and related diseases.

Disease Without Borders

September 26, 2014

In a paper published this week online in Global Society, researchers with University of California, San Diego School of Medicine and the Urban Studies and Planning Program, also at UC San Diego, present a bioregional guide that merges place-based (territorial) city planning and ecosystem management along the United States-Mexico border as way to improve human and environmental health.

UC San Diego Part of New Effort to Fight Autoimmune Disorders

September 25, 2014

The Division of Rheumatology, Allergy and Immunology at University of California, San Diego School of Medicine has been named a key site in a national, multi-institution, multi-year $41.6 million program to speed drug discovery, development, diagnostics and therapies for patients with autoimmune disorders, primarily rheumatoid arthritis (RA) and lupus erythematosus, which affect millions of Americans.

UC San Diego Health System Continues to Provide Exceptional Care by “Top Docs”

September 25, 2014

More than 100 physicians from UC San Diego Health System were named “Top Docs” in the annual San Diego Magazine “Physicians of Exceptional Excellence” annual survey. These physicians represent 40 diverse specialties, from internal medicine and oncology to obstetrics, cardiovascular and surgical care.

Looking Ahead: Whole Eye Transplant Under Development

September 22, 2014

The concept of a whole eye transplant seems futuristic, if not impossible. But with a $1million grant from the U.S. Department of Defense, researchers at University of California, San Diego School of Medicine hope to someday make implantation of an entire, functional eye a reality.

Not Skipping a Beat: Sulpizio Cardiovascular Center Again Among Nation’s Best

September 18, 2014

UC San Diego Sulpizio Cardiovascular Center (SCVC) has been named among "100 Hospitals with Great Heart Programs" by Becker's Hospital Review, a business and legal news publication for hospital and health system leadership.

Scientists Discover “Dimmer Switch” For Mood Disorders

September 18, 2014

Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as “disappointment.”

Novel Drug Targeting Leukemia Cells Enters Clinical Trial

September 16, 2014

Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common form of blood cancer in adults.
Category navigation with Social links